サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631233

持続グルコースモニタリングシステムの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Continuous Glucose Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 217 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
持続グルコースモニタリングシステムの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月06日
発行: Fairfield Market Research
ページ情報: 英文 217 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の持続グルコースモニタリング（CGM）システムの市場規模は、技術の進歩と糖尿病有病率の上昇に牽引され、今後数年間で大きな成長を遂げることが予想されます。CAGRは9.3%と堅調に拡大し、2025年には131億4,000万米ドル、2032年には244億9,000万米ドルに達すると予測されています。CGMシステムは糖尿病管理に革命をもたらし、グルコースの変動に関するリアルタイムの洞察を提供し、プロアクティブケアを可能にします。

持続グルコースモニタリングシステムは、高度なセンサーを利用することで、頻繁に指を刺して検査することなく、正確なリアルタイムのグルコースデータを提供します。この革新的なアプローチにより、患者とヘルスケアプロバイダーの糖尿病管理能力が向上しました。これらのシステムの採用は、その利点、改善された血糖コントロール能力、糖尿病管理における利便性に対する認識の高まりによって推進されています。CGMシステムとデジタルヘルスエコシステムとの統合は、その需要をさらに増大させています。

持続グルコースモニタリングシステム市場は、デジタルヘルス統合、個別化医療、拡大する地域市場に大きな機会が生まれ、変革的な成長を遂げる態勢が整っています。技術の進歩とヘルスケア政策の支援が引き続き市場の軌道を形成し、イノベーションを促進し、効果的な糖尿病管理ソリューションへの幅広いアクセスを確保します。

センサー技術の絶え間ない革新により、CGMシステムの精度、信頼性、使いやすさが向上しています。人工知能と機械学習別データ分析機能の向上は、より良い糖尿病管理のための実用的な洞察を提供します。座りっぱなしのライフスタイルや不健康な食習慣の増加により、世界的に糖尿病患者が増加しており、効果的なグルコースモニタリングソリューションに対する差し迫ったニーズが生まれています。北米などの地域では、包括的な償還イニシアティブと支持的な規制枠組みがCGMデバイスの採用を後押ししています。

当レポートでは、世界の持続グルコースモニタリングシステム市場について調査し、市場の概要とともに、コンポーネント別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 生産高と貿易統計、2019年～2023年

第4章 価格分析、2019年～2023年

第5章 世界の持続グルコースモニタリングシステム市場の見通し、2019年～2032年

  • 世界の持続グルコースモニタリングシステム市場の見通し、コンポーネント別、金額（10億米ドル）、数量（100万台）、2019年～2032年
  • 世界の持続グルコースモニタリングシステム市場の見通し、エンドユーザー別、金額（10億米ドル）、数量（100万台）、2019年～2032年
  • 世界の持続グルコースモニタリングシステム市場の見通し、地域別、金額（10億米ドル）、数量（100万台）、2019年～2032年

第6章 北米の持続グルコースモニタリングシステム市場の見通し、2019年～2032年

第7章 欧州の持続グルコースモニタリングシステム市場の見通し、2019年～2032年

第8章 アジア太平洋の持続グルコースモニタリングシステム市場の見通し、2019年～2032年

第9章 ラテンアメリカの持続グルコースモニタリングシステム市場の見通し、2019年～2032年

第10章 中東・アフリカの持続グルコースモニタリングシステム市場の見通し、2019年～2032年

第11章 競合情勢

  • メーカー別とエンドユーザー別のヒートマップ
  • 企業市場シェア分析、2022年
  • 競合ダッシュボード
  • 企業プロファイル
    • Herbalife Nutrition
    • GNC Holdings
    • NOW Health
    • Nutramax Laboratories
    • Nature's Bounty
    • Banyan Botanicals
    • Source Naturals
    • Nutramarks Inc
    • Nature's Way Products
    • Abbott
    • Natural Immunogenics

第12章 付録

目次

The global continuous glucose monitoring (CGM) systems market is set to witness significant growth in the coming years, driven by technological advancements and increasing diabetes prevalence. Forecasted to expand at a robust CAGR of 9.3%, the market is projected to achieve a valuation of $13.14 billion by 2025 and $24.49 billion by 2032. CGM systems have revolutionized diabetes management, offering real-time insights into glucose fluctuations and enabling proactive care.

Market Insights

Continuous glucose monitoring systems utilize advanced sensors to provide accurate, real-time glucose data without the need for frequent finger stick tests. This innovative approach has enhanced the ability of patients and healthcare providers to manage diabetes effectively. The adoption of these systems is being propelled by growing awareness of their benefits, improved glycemic control capabilities, and convenience in diabetes management. The integration of CGM systems with digital health ecosystems has further amplified their demand.

The continuous glucose monitoring systems market is poised for transformative growth, with significant opportunities emerging in digital health integration, personalized medicine, and expanding regional markets. Technological advancements and supportive healthcare policies will continue to shape the trajectory of the market, driving innovation and ensuring broader access to effective diabetes management solutions.

Key Market Drivers

  • Technological Advancements: Continuous innovation in sensor technology has enhanced the accuracy, reliability, and user-friendliness of CGM systems. Improved data analytics capabilities, powered by artificial intelligence and machine learning, provide actionable insights for better diabetes management.
  • Increasing Diabetes Prevalence: A rise in sedentary lifestyles and unhealthy dietary habits has escalated diabetes cases globally, creating a pressing need for effective glucose monitoring solutions.
  • Favorable Government Policies: Comprehensive reimbursement initiatives and supportive regulatory frameworks in regions like North America have encouraged the adoption of CGM devices.

Business Opportunities

  • Integration with Digital Health Platforms: CGM devices are increasingly being integrated with health apps, electronic health records (EHRs), and telehealth services, enabling comprehensive diabetes care and personalized interventions.
  • Emerging Markets in Asia Pacific: The rapidly growing diabetic population and healthcare infrastructure advancements in Asia Pacific present lucrative opportunities for CGM device manufacturers.
  • Expansion of Home Care Diagnostics: With a growing preference for decentralized healthcare, home care diagnostics is becoming a key segment, offering convenience and real-time glucose monitoring.

Regional Analysis

  • North America: The region dominates the global CGM market, supported by robust healthcare infrastructure, high diabetes prevalence, and significant investments in research and development. Favorable reimbursement policies further boost market growth.
  • Asia Pacific: Expected to register the fastest CAGR through 2032, the region's market growth is driven by an expanding diabetic population and increased adoption of advanced healthcare technologies in countries like China and India.
  • Europe: The market benefits from supportive government policies and rising awareness of advanced diabetes management solutions among healthcare providers and patients.

Key Players in the Market

Leading companies are implementing strategies to strengthen their market position:

  • Dexcom: Known for its advancements in sensor technology, offering devices with enhanced accuracy and longer operational durations.
  • Medtronic: Provides integrated diabetes management solutions combining CGM and insulin delivery systems.
  • Abbott Laboratories: Sets a benchmark for ease of use and affordability with its FreeStyle Libre system. Other notable players include Nature's Way Products, GNC Holdings, Banyan Botanicals, Nutramax Laboratories, and more.

Some key companies are:

  • Herbalife Nutrition
  • GNC Holdings
  • NOW Health
  • Nutramax Laboratories
  • Nature's Bounty
  • Banyan Botanicals
  • Source Naturals
  • Nutramarks Inc
  • Nature's Way Products
  • Abbott
  • Natural Immunogenics

Market Segmentation

  • By Component: Transmitters and Monitors Sensors Insulin Pumps
  • By End User: Home Care Diagnostics Hospitals ICU/Critical Care
  • By Region: North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Continuous Glucose Monitoring Systems Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Volume and Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. Pestle Analysis

3. Production Output and Trade Statistics, 2019 - 2023

  • 3.1. Global Continuous Glucose Monitoring Systems Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2019 - 2023

  • 4.1. Global Average Price Analysis, by Component, US$ Per Unit, 2019 - 2023
  • 4.2. Prominent Factor Affecting Continuous Glucose Monitoring Systems Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit, 2019 - 2023

5. Global Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 5.1. Global Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Transmitters and Monitors
      • 5.1.1.2. Sensors
      • 5.1.1.3. Insulin Pump
  • 5.2. Global Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Home Care Diagnostics
      • 5.2.1.2. Hospitals
      • 5.2.1.3. ICU/Critical Care
  • 5.3. Global Continuous Glucose Monitoring Systems Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. North America
      • 5.3.1.2. Europe
      • 5.3.1.3. Asia Pacific
      • 5.3.1.4. Latin America
      • 5.3.1.5. Middle East & Africa

6. North America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 6.1. North America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Transmitters and Monitors
      • 6.1.1.2. Sensors
      • 6.1.1.3. Insulin Pump
  • 6.2. North America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Home Care Diagnostics
      • 6.2.1.2. Hospitals
      • 6.2.1.3. ICU/Critical Care
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. North America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. U.S. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.2. U.S. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.3. Canada Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.4. Canada Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.2. Bps Analysis/Market Attractiveness Analysis

7. Europe Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 7.1. Europe Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Transmitters and Monitors
      • 7.1.1.2. Sensors
      • 7.1.1.3. Insulin Pump
  • 7.2. Europe Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Home Care Diagnostics
      • 7.2.1.2. Hospitals
      • 7.2.1.3. ICU/Critical Care
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Europe Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Germany Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.2. Germany Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.3. U.K. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.4. U.K. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.5. France Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.6. France Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.7. Italy Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.8. Italy Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.9. Turkey Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.10. Turkey Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.11. Russia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.12. Russia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.13. Rest Of Europe Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.14. Rest Of Europe Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.2. Bps Analysis/Market Attractiveness Analysis

8. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 8.1. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Transmitters and Monitors
      • 8.1.1.2. Sensors
      • 8.1.1.3. Insulin Pump
  • 8.2. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Home Care Diagnostics
      • 8.2.1.2. Hospitals
      • 8.2.1.3. ICU/Critical Care
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. China Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.2. China Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.3. Japan Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.4. Japan Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.5. South Korea Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.6. South Korea Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.7. India Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.8. India Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.9. Southeast Asia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.10. Southeast Asia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.11. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.12. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 9.1. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Transmitters and Monitors
      • 9.1.1.2. Sensors
      • 9.1.1.3. Insulin Pump
  • 9.2. Latin America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Home Care Diagnostics
      • 9.2.1.2. Hospitals
      • 9.2.1.3. ICU/Critical Care
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis
  • 9.3. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Brazil Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.2. Brazil Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.3. Mexico Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.4. Mexico Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.5. Argentina Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.6. Argentina Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.7. Rest Of Latin America Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.8. Rest Of Latin America Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.2. Bps Analysis/Market Attractiveness Analysis

10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 10.1. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.1.1. Key Highlights
      • 10.1.1.1. Transmitters and Monitors
      • 10.1.1.2. Sensors
      • 10.1.1.3. Insulin Pump
  • 10.2. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.2.1. Key Highlights
      • 10.2.1.1. Home Care Diagnostics
      • 10.2.1.2. Hospitals
      • 10.2.1.3. ICU/Critical Care
    • 10.2.2. BPS Analysis/Market Attractiveness Analysis
  • 10.3. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1. Key Highlights
      • 10.3.1.1. GCC Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.2. GCC Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.3. South Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.4. South Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.5. Egypt Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.6. Egypt Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.7. Nigeria Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.8. Nigeria Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.9. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.10. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. Manufacturer Vs by End User Heatmap
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Herbalife Nutrition
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Component Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. GNC Holdings
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Component Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. NOW Health
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Component Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Nutramax Laboratories
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Component Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Nature's Bounty
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Component Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Banyan Botanicals
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Component Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Source Naturals
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Component Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Nutramarks Inc
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Component Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Nature's Way Products
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Component Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. Abbott
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Component Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Natural Immunogenics
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Component Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms And Abbreviations